Case Report: Takotsubo Cardiomyopathy in Bickerstaff Brainstem Encephalitis Triggered by COVID-19.

Bickerstaff brainstem encephalitis Takotsubo cardiomyopathy anti-GQ1b ganglioside antibody coronavirus disease 2019 hemodynamic instability intravenous immunoglobulin therapy transthoracic echocardiogram

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2021
Historique:
received: 25 11 2021
accepted: 08 12 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 11 1 2022
Statut: epublish

Résumé

Takotsubo cardiomyopathy (TCM) is a stress-induced cardiomyopathy triggered by critical illness including severe neurological disorders. However, an association between TCM and Bickerstaff brainstem encephalitis (BBE) has rarely been described. During the current coronavirus disease 2019 (COVID-19) pandemic, growing evidence indicates that COVID-19 often leads to various neurological disorders, but there are few reports of an association between COVID-19 and BBE. Here we report a case of TCM associated with BBE triggered by COVID-19, which subsided with immunotherapy for BBE. Both transthoracic echocardiography and electrocardiography led to early and accurate diagnosis of TCM. Sustained hemodynamic instability due to TCM was immediately lessened with immunotherapy whereas additional plasmapheresis and immunotherapy were required to treat BBE. This case indicates that BBE might follow COVID-19 and TCM should be considered when hemodynamic status remains unstable in a patient with BBE.

Identifiants

pubmed: 35002947
doi: 10.3389/fneur.2021.822247
pmc: PMC8741194
doi:

Types de publication

Case Reports

Langues

eng

Pagination

822247

Informations de copyright

Copyright © 2021 Kimura, Hashiguchi, Tanaka, Hagiwara, Takahashi, Miyaji, Joki, Doi, Koga, Takeuchi and Tanaka.

Déclaration de conflit d'intérêts

HT is an Associate Editor of Frontiers in Neurology and Frontiers in Immunology. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurovirol. 2020 Apr;26(2):143-148
pubmed: 32447630
J Neurol Sci. 2021 Jan 15;420:117263
pubmed: 33321326
Card Fail Rev. 2018 May;4(1):14-20
pubmed: 29892470
Brain. 2003 Oct;126(Pt 10):2279-90
pubmed: 12847079
Neurol Sci. 2021 Mar;42(3):1181-1183
pubmed: 32975674
Int J Cardiol. 2014 Dec 15;177(2):322-9
pubmed: 25213573
Brain. 2021 Mar 3;144(2):682-693
pubmed: 33313649
J Neurol Sci. 2010 Apr 15;291(1-2):100-2
pubmed: 20117795
J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1210-5
pubmed: 22851608
QJM. 2021 May 19;114(3):204-205
pubmed: 32642763
CJC Open. 2021 May 26;3(10):1249-1256
pubmed: 34056570
J Am Coll Cardiol. 2020 Aug 4;76(5):628-629
pubmed: 32517962
Brain. 1982 Sep;105 (Pt 3):481-95
pubmed: 7104664
Environ Sci Pollut Res Int. 2021 May;28(17):20939-20944
pubmed: 33677662
J Neurol Sci. 1993 Aug;118(1):83-7
pubmed: 8229054
Monaldi Arch Chest Dis. 2020 Jul 29;90(3):
pubmed: 32724231
Heart Fail Clin. 2013 Apr;9(2):197-205, ix
pubmed: 23562120
Nat Rev Cardiol. 2010 Apr;7(4):187-93
pubmed: 20195267
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
J Neurol. 2021 Jun;268(6):2035-2037
pubmed: 32880723
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762

Auteurs

Mizuki Kimura (M)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Shunta Hashiguchi (S)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Kenichi Tanaka (K)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Manato Hagiwara (M)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Keita Takahashi (K)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Yosuke Miyaji (Y)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Hideto Joki (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Hiroshi Doi (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Michiaki Koga (M)

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Hideyuki Takeuchi (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Fumiaki Tanaka (F)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Classifications MeSH